Table Of Content

Journal of Clinical Pharmacy and Therapeutics (1999) 24, 471-473 AUTHOR INDEX Adu, A., Simpson, J.M. & Armour, C.L. Attitudes of pharmacists Delassus-Guenault, N., Jegouzo, A., Odou, P., Seguret, T., and physicians to antibiotic policies in hospitals, 181 Zangerlin, H., Vignole, E. & Robert, H. Clozapine-olanzapine: Akhondzadeh, S. see Noorbala, A.A. a potential dangerous switch. A report of two cases, 191 Akhondzadeh, S. Hippocampal synaptic plasticity and cognition, Dine, T. see Odou, P. 241 Dominguez-Gil, A. see Blanco Serrano, B Akhondzadeh, S., Mohammadi, M.R., Amini-Nooshabadi, H. & Dowell, A. see Gill, Po Davari-Ashtiani, R. Cyproheptadine in treatment of chronic Drake, C.I. see Peterson, G.M. schizophrenia: a double-blind, placebo-controlled study, 49 Amini-Nooshabadi, H. see Akhondzadeh, S. Flannery, M.A. What did doctors really do? In search of a Amini-Nooshabadi, H. see Noorbala, A.A. therapeutic perspective of American medicine, 151 Ansko, P. see Pahkla, R. Folb, P.1. see Valodia, P. Armour, C.L. see Adu, A. Forsyth, R.J. see Bergquist, P.A. Armour, C.L. see Taylor, S.J. Aukrust, A. see Priebe, H. Garcia Sanchez, M.J. see Blanco Serrano, B. Avery, A.J. see O'Neill, C. Georget, S., Vigneron, J., May, I., Perrin, A., Hoffman, M.A. & Avery, A.J., Groom, L.M., Brown, K.P., Thornhill, K. & Boot, D. Hoffman, M. Determination by capillary zone electrophoresis The impact of nursing home patients on prescribing costs in of mercaptopurine and thioguanine concentration in capsules g8 enerarlai fp raaccttiiccee,, 357/ for paediatric patients, 273 Gill, P.S. see Wearn, A.M. Gill, P.S., Dowell, A. & Harris, C.M. The effect of doctor ethnicity Baby, S., Nguyen, M., Tran, D. & Raffa, R.B. Substance P antag- and country of qualification on prescribing patterns: an eco- onists: the next breakthrough in treating depression?, 461 logical study, 197 Bacaltchuk, J., Trefiglio, R.P., De Oliveira, I.R., Lima, M.S. & Green, C.F., Mottram, D.R., Pirmohamed, M., Horner, R. & Rowe, Mari, J.J. Antidepressants versus psychotherapy for bulimia P.H. Communication regarding ADRs between secondary nervosa: a systematic review, 23 and primary care: a postal questionnaire survey of general Barnes, A.R. & Nash, S. Stability of ceftazidime in a viscous eye practitioners, 133 drop formulation, 299 Greenfield, S. see Jones, M. Bergin, J.K. see Peterson, G.M. Gressier, B. see Odou, P. Bergquist, P.A., Hunke, W.A., Reed, R.R., Manas, D., Forsyth, Groom, L. see O’Neill, C. R.J., Kenney, R.R., Cook, J. & Holahan, M. Compatibility Groom, L.M. see Avery, A.J of tirofiban HCl with dopamine HCl, famotidine, sodium Giingor, A. see Bozkir, A. heparin, lidocaine HCl and potassium chloride during simu- lated Y-site administration, 125 Harris, C.M. see Gill, P.S. Bjorsvik, H.-R. see Priebe, H. Henn, S., Monfort, P., Vigneron, J.H., Hoffman, M.-A. & Hoffman, Blanco Serrano, B., Garcia Sanchez, M.J., Otero, M.J., Santos M. Stability of methacholine chloride in isotonic sodium Buelga, D., Serrano, J. & Dominguez-Gil, A. Valproate popu- chloride using a electrophoresis assay, 365 lation pharmacokinetics in children, 73 Henry, R.Y. & O’Mahony, D. Treatment of prostate cancer, 93 Boot, D. see Avery, A.J. Higuchi, S. see Suematsu, F. Boot, D. see O'Neill, C. Hirakawa, M., Makino, K., Nakashima, K., Kataoka, Y. & Oishi, Booth, A. Pharm-ing cyberspace: the Internet as a tool for evi- R. Evaluation of the in-line filters for the intravenous infusion dence based pharmacotherapy, 159 of amphotericin B fluid, 387 Bozkir, A., Simsek, B., Giingér, A. & Torun, M. Ascorbic acid Hisawa, S. see Tanaka, E. and uric acid levels in lung cancer patients, 43 Ho, P.C. see Liu, J. Bradley, C. see Jones, M. Hoffman, M. see Georget, S. Brown, K.P. see Avery, A.J. Hoffman, M. see Henn, S. Brunet, C. see Odou, P.) Hoffman, M.A. see Georget, S. Hoffman, M.A. see Henn, S. Holahan, M. see Bergquist, P.A Chan, S.Y. see Liu, J. Holdaas, H. see Jardine, A. Chase, D. see C hristopher, F, Christ6pher, F., Chase, D., Stein, K. & Milne, R. rhDNASE therapy Horner, R. see Green, C.F. Hu, W.H. see Yang, Y.Y. for the treatment of cystic fibrosis patients with mild to Hunke, W.A. see Bergquist, P.A. moderate lung disease, 415 Chui, W.-K. see Lim, L.-Y. Irs, A. see Pahkla, R. Clark, W. see Misson, J. Cook, J. see Bergquist, P.A. Jaffrey, R. see Reeve, J.F. Jardine, A. & Holdaas, H. Fluvastatin in combination with Davari-Ashtiani, R. see Akhondzadeh, S. cyclosporin in renal transplant recipients: a review of clinical Davari-Ashtiani, R. see Noorbala, A.A. and safety experience, 397 Davies, P.D.O. see Pahkla, R. Jegouzo, A. see Delassus-Guenault, N. De Oliveira, I.R. see Bacaltchuk, J. Jones, M., Greenfield, S. & Bradley,C . A survey of the advertising Dehee, D. see Odou, P. of nine new drugs in the general practice literature, 451 © 1999 Blackwell Science Ltd 47] Author Index Jupe, D.M.L. see Peterson, G.M. Olson, W. see Petrone, D. Oselin, K. see Pahkla, R. Kamin, M. see Petrone, D. Otero, M.J. see Blanco Serrano, B. Kasina, R. see Puranajoti, P. Ovebode, F. sec Poolsup, N. Kataoka, Y. see Hirakawa, M. Kendall, M. see Nuttall, S.L. Pahkla, R., Irs, A., Oselin, K. & Rootslane, L. Digoxin: use pattern Kendall, M.J. & Toescu, V. Non-lipid properties of statins, 3 in Estonia and bioavailability of the local market leader, 375 Kendall, M.J. see Misson, J. Pahkla, R., Lambert, J., Ansko, P., Winstanley, P., Davies, P.D.O. Kendall, M.J., Toescu, V. & Nuttall, S.L. Angina and its treatment & Kiivet, R.-A. Comparative bioavailability of three different 171 preparations of rifampicin, 219 Kenney, R.R. see Bergquist, P.A. Peat, J.K. see Taylor, S.J. Kies, B.M. see Valodia, P. Perrin, A. see Georget, S. Kiivet, R.-A. see Pahkla, R. Peterson, G.M. see Reeve, J.F. Kilwein, ].H. Biases in medical literature, 393 Peterson, G.M. Drug misuse and harm reduction: pharmacy’s Kilwein, ].H. Metamorphosis, 1 magnificent contribution, but at what cost?, 165 Kilwein, ].H. What's in a name?, 81 Peterson, G.M., Drake, C.I., Jupe, D.M.L., Vial, J.H. & Wilkinson, S. Educational campaign to improve the prevention of post- Lambert, J. see Pahkla, R. operative venous thromboembolism, 279 Lambert, L. see Sarkar, P.K. Peterson, G.M., Wu, M.S.H. & Bergin, J.K. Pharmacists’ attitudes Li Wan Po, A. see Poolsup, N. towards dispensing errors: their causes and prevention, 57 Lim, L.-Y. & Chui, W.-K. P mhe armacist-operated drug information Petrone, D., Kamin, M. & Olson, W. Slowing the titration rate centres in Singapore, 4 3 of tramadol HCl reduces the incidence of discontinuation Lima, M.S. see Bacaltchuk, J. due to nausea and/or vomiting: a double-blind randomized Liu, J., Chan, S.Y. & Ho, P.C. Effects of sucrose, citric buffer trial, 103 and glucose oxidase on the stability of captopril in liquid Pirmohamed, M. see Green, C.F. formulations, 145 Poolsup, N., Li Wan Po, A. & Oyebode, F. Measuring mania: a Lloyd, D.C. & Roberts, D.J. Letter to the Editor, 157 critical appraisal of rating scales, 433 Luyckx, M. see Odou, P. Priebe, H., Aukrust, A., Bjorsvik, H.-R., Tonseth, C.P. & Wiggen, U.N. Stability of the X-ray contrast agent iodixanol = 3,3’, Makino, K. see Hirakawa, M. 5,5’ - tetrakis(2,3 - dihydroxypropylcarbamoy)) - 2,2’,4,4’,6,6’ - Manas, D. see Bergquist, P.A. hexaiodo-N,N’-(2-hydroxypropane-1,3-diyl)-diacetanilide to- Mari, J.J. see Bacaltchuk, J. wards acid, base, oxygen, 227 Martin, P. see Odou, P. Puranajoti, P., Kasina, R. & Tenjarla, S. Microbiological and HPLC May, I. see Georget, S. analysis of miconazole in skin, serum and phase-solubility Membre, S. see Odou, P. studies, 445 Milne, R. see Christopher, F. Minemoto, M. see Suematsu, F. Raffa, R.B. see Baby, S. Misson, J., Clark, W. & Kendall, M.J. Therapeutic advances: Reed, R.R. see Bergquist, P.A. leukotriene antagonists for the treatment of asthma, 17 Reeve, J.F., Peterson, G.M., Rumble, R.H. & Jaffrey, R. Programme Mohammadi, M.R. see Akhondzadeh, S. to improve the use of drugs in older people and involve Monfort, P. see Henn, S. general practitioners in community education, 289 Mottram, D.R. see Green, C.F. Robert, H. see Delassus-Guenault, N. Moulron, S. see Odou, P. Roberts, D.J. see Lloyd, D.C. Robinson, R.F. & Nahata, M.C. A comparative review of con- Nahata, M.C. see Robinson, R.F. ventional and lipid formulations of amphotericin B, 249 Nakashima, K. see Hirakawa, M. Rootslane, L. see Pahkla, R. Nash, S. see Barnes, A.R. Ross, J.D.C. see Tariq, A. Nguyen, M. see Baby, S. Rowe, P.H. see Green, C.F. Noorbala, A.A., Akhondzadeh, S., Davari-Ashtiani, R. & Amini- Rumble, R.H. see Reeve, J.F. Nooshabadi, H. Piracetam in the treatment of schizophrenia: implications for the glutamate hypothesis of schizophrenia, Santos Buelga, D. see Blanco Serrano, B. 369 Sarkar, P.K. & Lambert, L. Can lowering homocysteine levels Nuttall, S.L. see Kendall, M.]. reduce the incidence of stroke?, 331 Nuttall, S.L., Toescu, V. & Kendall, M. The incidence of sudden Seguret, T. see Delassus-Guenault, N. death in post-myocardial infarction beta-blocker trials, 237 Serfontein, J.H.P. see Truter, I. Serrano, J. see Blanco Serrano, B. O'Mahony, D. see Henry, R.Y. Seymour, M.A. see Valodia, P. O'Mahony, D. Prevention of corticosteroid-induced osteoporosis Sihorkar, V. see Vyas, S.P. and fractures, 83 Simpson, J.M. see Adu, A. O'Neill, C., Groom, L., Avery, A.J., Boot, D. & Thornhill, K. Simsek, B. see Bozkir, A. Explaining variations in prescribing costs: results from a Stein, K. see Christopher, F. comparison of nursing home patients with matched pairs Suematsu, F., Minemoto, M., Yukawa, E. & Higuchi, S. Population living in the community, 427 analysis for the optimization of digoxin treatment in Japanese Odou, P. see Delassus-Guenault, N. paediatric patients, 203 Odou, P., Martin, P., Membré, S., Gressier, B., Tamiji, L., Dine, T., Luyckx, M., Brunet, C., Dehee, D. & Moulron, S. Omeprazole- Tamiji, L. see Odou, P. induced leukopenia. A case study, 317 Tanaka, E. & Hisawa, S. Clinically significant pharmacokinetic Oishi, R. see Hirakawa, M. drug interactions with psychoactive drugs, 7 © 1999 Blackwell Science Ltd, Journal of Clinical Pharmacy and Therapeutics, 24, 471-473 Author Index Tanaka, E. Clinically significant pharmacokinetic drug inter- Valodia, P., Seymour, M.A., Kies, B.M. & Folb, P.l. Optimization actions between antiepileptic drugs, 87 of phenytoin therapy in adults with epilepsy in the Western Tanaka, E. Clinically significant pharmacokinetic drug inter- Cape, South Africa, 381 actions with benzodiazepines, 347 Vial, J.H. see Peterson, G.M Tanaka, E. Gender-related differences in pharmacokinetics and Vigneron, J. see Georget, S. their clinical significance, 339 Vigneron, J.H. see Henn, S. Tanaka, E. Update: genetic polymorphism of drug metabolizing Vignole, E. see Delassus-Guenault, N. enzymes in humans, 323 Vyas, S.P. & Sihorkar, V. Exploring novel vaccines against Helico- Tariq, A. & Ross, J.D.C. Bacterial sexually transmitted infections: bacter pylori: protective and therapeutic immunization, 259 current management strategies, 53 Tariq. A x Ross, J.D.C. Viral sexually transmitted infections: Wearn, A.M. & Gill, PS. Hormonal emergency contraception: current management strategies, 409 moving over the counter?, 313 Taylor, S.J., Peat, J.K. & Armour, C.L. An evaluation of prosta- Wiggen, U.N. see Priebe, H glandin E, vaginal gel use in practice, 303 Wilkinson, S. se’ Peterson, G.M. Tenjarla, S. see Puranajoti, P. Winstanley, P see Pahkla, R. Thornhill, K. see Avery, A.J. Wu, M.S.H. see Peterson, G.M Thornhill, K. see O'Neill, C. Toescu, V. see Kendall, M,]. Yang, Y.Y. & Hu, W.H. Only relatively higher and lower Li~ ratio Toescu, V. see Nuttall, S.L. might predict clinical responses, 141 Tonseth, C.P. see Priebe, H. Yukawa, E. Population-based investigations of drug relative Torun, M. see Bozkir, A clearance using nonlinear mixed-effect modelling from infor- Tran, D. see Baby, S. mation generated during the routine clinical care of patients, Trefiglio, R.P. see Bacaltchuk, J. 113 Truter, I. & Serfontein, J].H.P. A survey of the treatment of female Yukawa, E. see Suematsu, F. patients with osteoporosis using drug utilisation con- sumption parameters, 209 Zangerlin, H. see Delassus-Guenault, N. 5 © 1999 Blackwell Science Ltd, Journal of Clinical Pharmacy and Therapeutics, 24, 471-473